Exact Sciences' Q4 results beat analysts' expectations

Exact Sciences has applied for federal approval of a “next-generation” Cologuard test, meaning the new version of its stool-based test to screen for colon cancer could become available by 2025.

Related Keywords

Kevin Conroy ,Sciences Corp ,Zacks Investment Research ,Madison Based Exact Sciences ,Exact Sciences ,